Use of nitric oxide and a device in the therapeutic management of pathogens in mammals
OwnerDoug Hole, Christopher Millerinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for the systemic delivery of the nitric oxide moiety either as a dissolved gas or through the administration of nitric oxide donors in an extracorporeal circuit to reduce whole body bacterial contamination by pathogenic or toxic substrates. The utilization of an extracorporeal circuit with the entrainment of nitric oxide is viewed as a novel modality in the medical management of bacteremia (blood poisoning) and/or septicemia in mammals.
Claims25
A method of reducing pathogens in a mammal's blood stream by exposing the blood in an extracorporeal fluid with nitric oxide, comprising:
- (a) providing an extracorporeal blood circuit comprising an inlet line adapted to receive blood from a patient or a blood source, an outlet line adapted to return blood to the patient and/or the blood source, a fluid circuit for fluid communication between the inlet and the outlet line, and at least one pump acting on the fluid circuit to circulate blood therethrough and out the outlet line,
- (b) circulating the blood through the extracorporeal blood circuit, and
- (c) exposing the blood in the circuit with nitric oxide gas in a concentration sufficient to reduce pathogenic content in the blood.
A method of reducing pathogens in blood in an extracorporeal fluid circuit of a cardiopulmonary bypass apparatus, comprising:
- providing a cardiopulmonary bypass circuit that includes an inlet line adapted to receive blood from a patient or a blood source and an outlet line adapted to return blood to the patient and/or blood source, a reservoir connected to the inlet line for accumulation of blood received from the patient, an oxygenator, a fluid interconnection circuit for fluid communication between the reservoir and the oxygenator and between the oxygenator and the outlet line, and at least one pump acting on the fluid interconnection circuit to withdraw blood from the reservoir and circulate it through the oxygenator and out the outlet line, and
- exposing the blood in a portion of the cardiopulmonary bypass circuit with nitric oxide gas in concentration sufficient to reduce pathogens in the blood.
An extracorporeal blood circuit comprising an inlet line adapted to receive blood from a patient or a blood source, an outlet line adapted to return blood to the patient and/or the blood source, a fluid circuit for fluid communication between the inlet and the outlet line, and at least one pump acting on the fluid circuit to circulate blood therethrough and out the outlet line,
- a nitric oxide unit that exposes the blood in the circuit with nitric oxide gas in a concentration sufficient to reduce pathogenic content in the blood;
- and
- a free radical scavenger unit that exposes the blood in the circuit and after being exposed to nitric oxide, with a free-radical scavenger in a concentration sufficient to reduce the nitric oxide content in the blood.
A nitric oxide gas dispenser for mammals, comprising:
- a component that provides nitric oxide gas and or aerosolized composition at a desired pressure and concentration, and a delivery system that provides the nitric oxide at the desired pressure to the mammal;
- a valve mechanism that controls the flow of the nitric oxide so the mammal's lungs receive a predetermined amount of nitric oxide and the nitric oxide is of sufficient quantity that it is able to penetrate through the mammal's lungs to contact the mammal's blood cells to reduce the pathogens in the mammal's blood and not form excessive amounts of methemoglobin.
A method of reducing pathogens in a mammal's blood stream by exposing the blood that receives oxygen from the lungs with nitric oxide, comprising:
- (a) administering nitric oxide from a nitric oxide dispenser unit to a mammal through a nasal canula, a mask or a ventilator circuit for a mammal breathing or on ventilator like support;
- (b) exposing the blood in contact with the patient's lungs with nitric oxide in a concentration sufficient to reduce pathogenic content in the blood.
Dependencies are inferred from the claim text.